SCHEMBL14770705

SCHEMBL14770705

c1ccc2c(c1)c1ccccc1n2-c1ccc2oc3ccc(-c4ccnc(-n5c6ccccc6c6ccccc65)c4)cc3c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
PDE3B Q13370 2/20 0.35
PDE3A Q14432 2/20 0.35
KDM4E B2RXH2 3/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAPT P10636 3/20 0.34
NPC1 O15118 2/20 0.34
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
DYRK1A Q13627 1/20 0.32
PLA2G10 O15496 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MEN1 O00255 1/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10041344 0.88 KDM4E (0.35) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL2628401 0.87 KDM4E (0.46) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL280420 0.87 KDM4E (0.46) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL15780991 0.87 KDM4E (0.46) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL14770641 0.86 NPC1 (0.39) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL14770639 0.86 KDM4E (0.34) KDM4EATML3MBTL1MAPTNPC1
SCHEMBL12455083 0.85 PLA2G2A (0.42) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL17952845 0.85 KDM4E (0.42) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL17952833 0.85 KDM4E (0.42) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL13383764 0.85 KDM4E (0.44) KDM4EATML3MBTL1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L PDE4A 4706/4885PDE4B 4615/4885PDE4C 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.